Medicamen Organics is set to launch its Initial Public Offering (IPO) on June 21, with the opportunity for investors to participate until June 25.
Here are the key details:
This IPO presents an opportunity for investors to participate in the growth potential of Medicamen Organics,
with optimistic expectations from the grey market and analysts alike.
Opening and Closing Dates: The IPO opens for investment on June 21 and closes on June 25.
Price Band: The IPO price is fixed at Rs 34 per share.
Lot Size and Investment Requirement: The lot size for the IPO is 4,000 shares, requiring a minimum investment of ₹136,000 for retail investors.
Type of IPO: Medicamen Organics’ IPO falls under the SME IPO category.
Allotment and Listing Dates
Allotment of shares will take place on June 26, and the listing on NSE SME is scheduled for June 28.
Financial Performance and Management
Medicamen Organics reported a net profit of ₹95.78 lakh on revenue of ₹22.96 crore in FY23.
The IPO is managed by GYR Capital Advisors Pvt Ltd as the book running lead manager, with KFin Technologies serving as the IPO registrar.
The company is promoted by Bal Kishan Gupta.
Grey Market Premium (GMP) Analysis
Currently, Medicamen Organics’ shares are trading in the grey market at a premium of ₹60 per share over the issue price of ₹34.
Analysts suggest that the listing price could be around ₹94 per share, indicating a potential increase of approximately 177% from the IPO price.
By providing this structured overview, potential investors can better understand the key aspects and potential returns associated with investing in Medicamen Organics’ IPO.
